FREMS – INNOVATION IN THE TREATMENT OF, AMONG OTHER THINGS. DIABETIC NEUROPATHY!

Frequency Rhythmic Electrical Modulation System – generation of biocompatible electrical signals by computerized neurostimulators and their delivery via transcutaneous electrodes.

Fremslife has developed an innovative and integrated solution for treating and reducing pain associated with neurovascular conditions based on electroceutical-oriented therapeutic and diagnostic programs. At the heart of Fremslife’s technology is Frems™ (Rhythmic Electrical Frequency Modulation System).
Frems™ is a technology protected by more than 10 international patents and certified by the US FDA.
It is the only neurostimulation technology with scientifically proven neoangiogenetic effects by promoting the release and synthesis of growth factors. Its action effectively reduces pain from the first treatment. The system is ideal for treating conditions and injuries in the acute phase; it is ideally compatible with other therapeutic protocols and achieves exceptional results even in patients with ailments resistant to other therapies or treatments.

VISIT: WWW.FREMS.PL

Scroll to Top